Abstract:BACKGROUND:Implantation of current used bare metal stent,metal drug-eluting stent,or alloy stent would result in local intimal hyperplasia,thrombosis and increase incidence of adverse cardiovascular event. Therefore,the development and preparation of high molecular polymer biodegradable stent has aroused increasing attention. OBJECTIVE:To study the behavior and histocompatibility of novel fully biodegradable material of poly trimethylene carbonate-co-d,l-lactide(PDLLA/TMC) in vivo. METHODS:The early-stage synthetized materials of PDLLA/TMC(50/50) were used in the experiment group and the PLLA/TMC(50/50) and PLLA in the control. The patches of each kind of the three polymers above were implanted into the subcutaneous tissue of the 144 Wistar mouse with equal gender,six months old. The polymers patches and their surrounding tissues were taken out and weighed and sliced for hematoxylin-esoin staining at the phases of different test time. Their biodegradable behaviors in vivo were tested by the methods of size exclusion chromatography(SEC) ,gel permeation chromatography(GPC) ,nuclear magnetic resonance(NMR) and environmental scanning electron microscope(ESEM) ,and their histocompatibility was evaluated by inflammation cells counting in quantity with light microscope. RESULTS AND CONCLUSION:In the first 60 days of implantation,there was no significant difference in the percentage of mass loss among the three groups,and their velocity of degradation was relatively slow,though it was slightly faster in the PDLLA/TMC than in the PLLA/TMC and PLLA. During the 60 days to 180 days,PDLA/TMC degradation velocity accelerated obviously,and its percentage of mass loss was much higher than the other two polymers. At 180 days,most of the PDLLA/TMC degraded while the PLLA/TMC and PLLA degraded less. When the three polymers were implanted into the mouse body,at first their molecular declined rapidly,then the decline went into a slow stage gradually. With the time extended,their smooth and orderly superficial structure transformed into ruffle,twist,turbulent,full of hole and hollow,which was rather obvious in the polymer of PDLLA/TMC. Also,there were relative lower inflammation cells counting in the PDLLA/TMC and PLLA/TMC group at the phase of different test time,compared to the PLLA group the differences had statistic significance(P < 0.05) ,but there was no statistic significance between the PDLLA/TMC and PLLA/TMC group(P > 0.05) . The polymer of PDLLA/TMC,which has favorable degradation performance and histocopatibility,is a novel fully biodegradable material and capable of manufacturing the implanted cardiovascular stent.

In Vivo Degradation of Copolymers Prepared from L-Lactide, 1,3-Trimethylene Carbonate and Glycolide As Coronary Stent Materials

In Vitro Degradation of Poly[(L‐lactide)‐co‐(trimethylene Carbonate)] Copolymers and a Composite with Poly[(L‐lactide)‐co‐glycolide] Fibers As Cardiovascular Stent Material

Cytocompatibility Evaluation of a Novel Series of PEG-Functionalized Lactide-Caprolactone Copolymer Biomaterials for Cardiovascular Applications

In Vitro Degradation Behavior of L-Lactide/Trimethylene Carbonate/Glycolide Terpolymers and A Composite with Poly(L-Lactide-Co-Glycolide) Fibers

Evaluation of Bioresorbable Polymers As Potential Stent Materialin Vivo Degradation Behavior and Histocompatibility

In Vivo Study on the Histocompatibility and Degradation Behavior of Biodegradable Poly(Trimethylene Carbonate-Co-D,L-Lactide)

Synthesis and Properties of Trimethylene Carbonate-L-Lactide-Glycolide Terpolymers

In Vitro Biocompatibility Evaluation of Bioresorbable Copolymers Prepared from L-Lactide, 1, 3-Trimethylene Carbonate, and Glycolide for Cardiovascular Applications

Microstructure–property Relationship of L-Lactide/trimethylene Carbonate/glycolide Terpolymers As Cardiovascular Stent Material

Totally Bioresorbable Composites Prepared from Poly(l‐lactide)‐co‐(trimethylene Carbonate) Copolymers and Poly(l‐lactide)‐co‐(glycolide) Fibers As Cardiovascular Stent Material

A Novel Biodegradable Copolymer for Coronary Artery Stent: Preparation and its Biocompatibility in vivo

Effect of Trimethylene Carbonate Segments on the Structure and Properties of Poly(l‐lactide‐glycolide‐trimethylene Carbonate) Terpolymers for Biodegradable Vascular Stents

Haemo- and cytocompatibility of bioresorbable homo- and copolymers prepared from 1,3-trimethylene carbonate, lactides, and ε-caprolactone

In vitro degradation and biocompatibility evaluation of fully biobased thermoplastic elastomers consisting of poly(β-myrcene) and poly( -lactide) as stent coating

Enzyme-catalyzed Degradation Behavior of L-Lactide/trimethylene Carbonate/glycolide Terpolymers and Their Composites with Poly(l-Lactide-co-glycolide) Fibers

In vivo degradation behavior and histocompatibility of a novel fully biodegradable material:Poly trimethylene carbonate-Co-D,L-Lactide

In Vitro and in Vivo Degradation Behavior of Poly(Trimethylene Carbonate-Co-D, L-Lactic Acid) Copolymer

Computational and Experimental Investigation into Mechanical Performances of Poly-L-Lactide Acid (PLLA) Coronary Stents

Biodegradable Poly(trimethylene Carbonate‐b‐(l‐lactide‐ran‐glycolide)) Terpolymers with Tailored Molecular Structure and Advanced Performance

Structure, Properties, and in Vitro Degradation Behavior of Biodegradable Poly(l‐lactic Acid)‐trimethylene Carbonate‐glycolide Terpolymer

Effect Of Segment Structures On The Hydrolytic Degradation Behaviors Of Totally Degradable Poly(L-Lactic Acid)-Based Copolymers